The U.S. dental implant market might be hurting right now because of the economic recession, but it will recover after 2010 and exceed $1 billion by 2013, according to Millennium Research Group’s latest market report, “U.S. Markets for Dental Implants 2009.”
In the current economic climate, patients are opting for less expensive alternatives to implants, such as crowns and bridges. This means that dentists are now buying smaller volumes of dental implant products, according to Millennium.
“With economic recovery expected to begin in 2010, however, market growth will be stimulated by preference for minimally invasive procedures that offer improved aesthetic results and boast shorter treatment lengths,” the company stated in a press release.
“The growing population of general practitioners (GPs) placing dental implants will also lead to steady market growth, particularly with small-diameter implants that are easier to place and less invasive,” said Poonam Jassi, senior analyst at Millennium, in the release.
The report provides coverage of key industry competitors, including Astra Tech, Bicon Dental Implants, BioHorizons, Biomet 3i, Dentsply, Implant Direct, Imtec, Keystone Dental, Nobel Biocare, Straumann, and Zimmer Dental.
